Home/Filings/4/0001179110-16-020019
4//SEC Filing

MOMENTA PHARMACEUTICALS INC 4

Accession 0001179110-16-020019

CIK 0001235010operating

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 11:53 AM ET

Size

6.1 KB

Accession

0001179110-16-020019

Insider Transaction Report

Form 4
Period: 2016-02-22
Bishop John E
Senior VP, Pharmaceutical Scie
Transactions
  • Sale

    Common Stock

    2016-02-22$9.65/sh227$2,191107,188 total
  • Sale

    Common Stock

    2016-02-23$9.80/sh102$1,000107,086 total
Footnotes (2)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2009.
  • [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2015.

Issuer

MOMENTA PHARMACEUTICALS INC

CIK 0001235010

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001235010

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 11:53 AM ET
Size
6.1 KB